Société Synthetic Biologics Inc Nyse
Actions
US87164U1025
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 62 | 01/06/15 | |
Michael Kaleko
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/12 |
- | - | ||
T. J. Swope
SEC | Corporate Secretary | - | - |
Manel Cascalló
PRN | Corporate Officer/Principal | - | 23/03/22 |
Vince Wacher
PRN | Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Jeff Wolf
BRD | Director/Board Member | 60 | 01/01/06 |
John Monahan
BRD | Director/Board Member | 77 | 11/11/20 |
Jeffrey Kraws
CHM | Chairman | 59 | 01/01/06 |
Chief Executive Officer | 62 | 01/06/15 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 17 868 282 | 16 816 750 ( 94,12 %) | 720 233 ( 4,031 %) | 94,12 % |
Coordonnées société
Theriva Biologics, Inc.
9605 Medical Center Drive Suite 270
20850, Rockville
+301 417 4364
http://www.therivabio.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+3,91% | 109 Md | |
+10,87% | 105 Md | |
+1,28% | 22,25 Md | |
-13,14% | 22,09 Md | |
-7,05% | 18,68 Md | |
-38,36% | 17,58 Md | |
-10,66% | 16,85 Md | |
+3,75% | 13,76 Md | |
+36,70% | 12,46 Md |